All materials displayed at SupplySide events are subject to the SupplySide Compliance Program. This includes, but is not limited to: booth displays, package labeling and inserts, descriptions of ingredients and services, promotional materials, websites, videos or anything presented at the show.
Prohibited claims
Product information being disseminated at any SupplySide event must meet the following standards:
- Disease claims are prohibited for dietary supplements. Promotion of a product to treat, prevent, mitigate or cure any disease or condition including but not limited to diabetes, cancer, flu, cold, heart disease or Alzheimer's disease is not permitted for dietary supplements.
- Claims based on traditional use must clearly communicate that the sole basis for the claim is its history of use for a particular purpose.
- Claims must be appropriate for dietary supplements and not advertise the product as a "drug" under the FDCA (Federal Food, Drug and Cosmetic Act).
Claims that are a high priority for FDA include (but are not limited to): weight loss, body building, sexual enhancement and products for children. For more information about claims that can be made for conventional foods and dietary supplements, click here.
Prohibited ingredients
Ingredients that are banned from any use in the United States include, but are not limited to: ephedra/ephedrine, masking agents, narcotics. Also prohibited are ingredients that are not appropriate for the application, including but not limited to: anabolic steroids, and drug ingredients in food, beverage or dietary supplement ingredients.
Prohibited food and dietary supplement ingredients that are a high priority to the U.S. Food and Drug Administration (FDA) include (but are not limited to): anabolic steroids and anabolic steroid pre-cursors, masking agents, ephedra/ephedrine, narcotics.
For more information on industry information and regulations, click here.
Prevention of Adulterated Products
Adulteration is a global problem. SupplySide does not perform testing nor do we require lab analyses on products presented at our events. However, consumer safety is important to us. In our effort to protect consumers by removing adulterated products from global commerce, SupplySide (Informa) strongly encourages all buyers and sellers to be aware of the Botanical Adulterants Prevention Program (BAPP) and to begin using the BAPP Best Practices for the Disposal / Destruction of Irreparably Defective Articles (“IDAs”). To learn more about how to support and use this initiative to help solve a global problem, click here.
SupplySide's hemp and cannabinoid policy
The SupplySide Compliance Program has adopted this policy for products that contain hemp and hemp-derived cannabinoids to help ensure the industry complies with existing regulations and to encourage best practices that help ensure quality and transparency. Acceptance as an exhibitor or advertiser and approval for exhibition or advertisement of any cannabinoid product at a SupplySide event is NOT a determination that the product complies with all local, state and federal laws, all of which may vary. Neither is it, nor is it intended to be, legal advice; exhibitors should always seek the advice of a qualified attorney.
Review criteria*:
When reviewing cannabinoid products, our highest priorities are safety, transparency, truthfulness, reliability and responsibility.
1. Products cannot contain more than 0.3% THC.
2. Disease claims and all claims explicitly rejected by FDA, e.g., chronic anxiety, are prohibited.
3. Products may not be marked for psychoactive effects.
4. All statements must be substantiated.
5. Transparency, clarity and truthfulness in labeling are required.
6. Responsibility and care for vulnerable populations are required.
7. Vapes and vape accessories are prohibited.
8. Devices, including patches, are required to have appropriate FDA clearance (510k, PMA, registration and/or listing).
9. Exhibit review and approval is on a product-by-product basis.
*Violation of this show policy resolution will be considered a material violation of the show rules and regulations, and may result in the exhibitor’s removal from the venue at the venue's or show host management’s sole and absolute discretion.
Prohibited use of FDA logo
The FDA logo is for the official use of FDA and not for use on private sector materials. To the public, such use would send a message that FDA favors or endorses a private sector organization or the organization’s activities, products, services and/or personnel (either overtly or tacitly), which FDA does not and cannot do. Unauthorized use of the FDA logo may violate federal law and subject those responsible to civil and/or criminal liability.
For more information on the use of the FDA logo, click here.
